194
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Prognostic significance of platelet count changes during hospitalization for community-acquired pneumonia

, , , , , , , , & show all
Pages 380-386 | Received 26 Jun 2016, Accepted 19 Jul 2016, Published online: 29 Sep 2016

References

  • Kamath S, Blann AD, Lip GY. Platelet activation: Assessment and quantification. Eur Heart J 2001;22:1561−1571.
  • Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005;115:3339−3347.
  • Deutsch VR, Tomer A. Advances in megakaryocytopoiesis and thrombopoiesis: From bench to bedside. Br J Haematol 2013;161:778−793.
  • Nijsten MW, ten Duis HJ, Zijlstra JG, Porte RJ, Zwaveling JH, Paling JC, The TH. Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med 2000;28:3843−3846.
  • Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med 2002;30:753−756.
  • Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: Bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002;30:1765−1771.
  • Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar JR, Adrie C, Vincent F, Cohen Y, Schlemmer B, Azoulay E. Platelet count decline: An early prognostic marker in critically ill patients with prolonged ICU stays. Chest 2007;131:1735−1741.
  • Shteinshnaider M, Barchel D, Almoznino-Sarafian D, Tzur I, Tsatsanashvili N, Swarka M, Cohen N, Gorelik O. Clinical characteristics and prognostic significance of changes in platelet count in an internal medicine ward. Eur J Intern Med 2014;25:646−651.
  • Williamson DR, Lesur O, Tétrault JP, Nault V, Pilon D. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes. Can J Anaesth 2013;60:641−651.
  • Wunderink RG, Waterer GW. Community-acquired pneumonia. N Engl J Med 2014;370:543−551.
  • Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015;373:415−427.
  • Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Ten-year mortality after community-acquired pneumonia: a prospective cohort. Am J Resp Crit Care Med 2015;192:597−604.
  • Mirsaeidi M, Peyrani P, Aliberti S, Filardo G, Bordon J, Blasi F, Ramirez JA. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest 2010;137:416−420.
  • Prina E, Ferrer M, Ranzani OT, Polverino E, Cillóniz C, Moreno E, Mensa J, Montull B, Menéndez R, Cosentini R, Torres A. Thrombocytosis is a marker of poor outcome in community-acquired pneumonia. Chest 2013;143;767−775.
  • Brogly N, Devos P, Boussekey N, Georges H, Chiche A, Leroy O. Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect 2007;55:136−140.
  • Ross DW, Ayscue LH, Watson J, Bentley SA. Stability of hematologic parameters in healthy subjects. Intraindividual versus interindividual variation. Am J Clin Pathol 1988;90:262−267.
  • Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimation glomerular filtration rate. Ann Intern Med 2006;145:247−254.
  • Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377−382.
  • Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243−250.
  • Dixon WJ (Chief editor). BMDP statistical software. Los-Angeles: University of California Press; 1993.
  • Ware J, Corken A, Khetpal R. Platelet function beyond hemostasis and thrombosis. Curr Opin Hematol 2013;20:451−456.
  • Yeaman MR, Bayer AS. Antimicrobial peptides versus invasive infections. Curr Top Microbiol Immunol 2006;306:111−152.
  • Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systemic review and meta-analysis. J Thromb Haemost 2010;8:148−156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.